Silence Therapeutics Plc (SLNCF)
1.06
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Silence Therapeutics Total Liabilities (Quarterly) : 65.72M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| NuCana Plc | 6.839M |
| Mereo BioPharma Group Plc | 6.56M |
| Compass Pathways Plc | 205.05M |
| Immunocore Holdings Plc | 678.42M |
| Genflow Biosciences Plc | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.12M |
| Shareholders Equity (Quarterly) | 49.40M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 9.833 |
| Net Debt Paydown Yield | 0.00% |